SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 149, Medical Device Access and Innovation Protection Act H.R. 160, Protect Medical Innovation Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Special Assistant, HHS; Counsel, Senate Budget Committee; Counsel, House Budget Committee. |
Budget/Appropriations BUD
H.R. 1078, Food and Drug Administration Safety Over Sequestration Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Special Assistant, HHS; Counsel, Senate Budget Committee; Counsel, House Budget Committee. |
Health Issues HCR
Education regarding hysteroscopic tissue removal. Mobile medical technologies provisions in the 21st Century Cures legislation. Custom Device Exemption: FDA Final Guidance for Industry and Food and Drug Administration Staff.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Special Assistant, HHS; Counsel, Senate Budget Committee; Counsel, House Budget Committee. |
Medicare/Medicaid MMM
Lobbying related to Medicare policies that promote bundled payments. Lobbying related to implementation of the ICD-10 coding system. Lobbying related to Medicare Part D drug rebate proposals. Patient Access to Disposable Medical Technology Act (H.R. 1018) and 21st Century Cures legislation. CY 2015 Medicare final rule for hospital outpatient prospective payment system and ambulatory surgical center payment system: Provisions related to packaging of drugs and biologicals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL SELTMAN | Special Assistant, HHS; Counsel, Senate Budget Committee; Counsel, House Budget Committee. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.